Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways
- PMID: 8510012
Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways
Abstract
The effect of genetic obesity and phenobarbital treatment on hepatic conjugation pathways was evaluated in the obese Zucker rat. Acetaminophen pharmacokinetic parameters were examined in vivo after a 30-mg/kg acetaminophen intravenous bolus dose in the presence and absence of phenobarbital treatment. Glucuronidation and glutathione conjugation pathways were studied in vitro in obese and lean Zucker rats after phenobarbital treatment. Obese Zucker rats demonstrated a higher glucuronidation capacity as evidenced by a higher formation clearance of acetaminophen glucuronide and greater UDP-glucuronosyltransferase (UDPGT) activity toward acetaminophen and p-nitrophenol compared with lean controls. Sulfate and glutathione conjugation pathways were not affected by genetic obesity. Obese Zucker rats possessed a higher total hepatic glutathione content due to greater liver weight. Phenobarbital treatment enhanced glucuronidation of acetaminophen and structurally related compounds (i.e., p-nitrophenol) similarly in both phenotypes, but the treatment failed to induce morphine UDPGT in the obese Zucker rat. No effect of phenobarbital was observed on sulfate conjugation, gamma-glutamyl cysteine synthetase activity or hepatic glutathione content in obese or lean Zucker rats. Similar increases in glutathione transferase activities were observed in animals of both phenotypes after phenobarbital treatment. This study demonstrates that glucuronidation is enhanced in genetically obese rats, whereas phenobarbital causes normal induction of several enzymes of the glucuronidation and glutathione conjugation pathways in the obese Zucker rat. However, morphine UDPGT was not induced by phenobarbital, suggesting that obese Zucker rats may possess a defect in the induction of this enzyme similar to that already described for the CYP2B gene in this strain.
Similar articles
-
Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent.J Pharmacol Exp Ther. 1987 Nov;243(2):565-70. J Pharmacol Exp Ther. 1987. PMID: 3681696
-
Acetaminophen hepatotoxicity: influence of phenobarbital and beta-naphthoflavone treatment in obese and lean Zucker rats.Toxicol Appl Pharmacol. 1993 Dec;123(2):219-25. doi: 10.1006/taap.1993.1240. Toxicol Appl Pharmacol. 1993. PMID: 8248929
-
Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.J Pharmacol Exp Ther. 1984 Dec;231(3):654-9. J Pharmacol Exp Ther. 1984. PMID: 6502519
-
Paracetamol metabolism and related genetic differences.Drug Metab Rev. 2011 Feb;43(1):41-52. doi: 10.3109/03602532.2010.527984. Epub 2010 Nov 25. Drug Metab Rev. 2011. PMID: 21108564 Review.
-
Overview of in vitro metabolism of drugs by aquatic species.Vet Hum Toxicol. 1986;28 Suppl 1:2-8. Vet Hum Toxicol. 1986. PMID: 3151420 Review.
Cited by
-
The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.Pharmacol Ther. 2007 Jan;113(1):88-120. doi: 10.1016/j.pharmthera.2006.07.004. Epub 2006 Nov 13. Pharmacol Ther. 2007. PMID: 17097148 Free PMC article. Review.
-
Western Diet Decreases Hepatic Drug Metabolism in Male LDLr-/-ApoB100/100 Mice.J Nutr Metab. 2023 Mar 31;2023:5599789. doi: 10.1155/2023/5599789. eCollection 2023. J Nutr Metab. 2023. PMID: 37034183 Free PMC article.
-
Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen.Clin Pharmacokinet. 2016 Jul;55(7):833-847. doi: 10.1007/s40262-015-0357-0. Clin Pharmacokinet. 2016. PMID: 26818482 Free PMC article.
-
An integrated functional genomic study of acute phenobarbital exposure in the rat.BMC Genomics. 2010 Jan 6;11:9. doi: 10.1186/1471-2164-11-9. BMC Genomics. 2010. PMID: 20053287 Free PMC article.
-
Drug metabolism alterations in nonalcoholic fatty liver disease.Drug Metab Rev. 2011 Aug;43(3):317-34. doi: 10.3109/03602532.2011.577781. Epub 2011 May 25. Drug Metab Rev. 2011. PMID: 21612324 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical